ACRO in ACTION: Insights from the COVID-era

The COVID-19 pandemic has sparked extraordinary activity in the clinical research and technology industry. Urgency has driven evolution: The industry has adapted, taken risks and innovated – with changes large and small – in response to a global crisis. Check out our series of blog posts, interviews, and videos from our members companies on how they have adapted and innovated in the COVID-era. 

The need for new paradigms

“The pandemic has changed everything about the pace of our innovation and our focus,” says Peyton Howell, EVP and Chief Commercial &…

A Catalyst for Innovation, Urgency for Now, Momentum for the Future

For Dr. Sy Pretorius, Parexel’s Chief Medical & Scientific Officer, COVID-19 has been a catalyst. The pandemic has accelerated innovations that make…

Sharpening the pencil: Rethinking trial design with the patient at the center

New medicines are at the core of clinical research. Historically in clinical research, these experimental medicines move from a warehouse to a…

Patient engagement, thinking ahead and how the clinical research industry helps solve global problems: A conversation with Alistair Macdonald – Part 2

In August 2020, Syneos Health CEO Alistair Macdonald reflected on the COVID-19 crisis to date. Read Part 1 of the conversation. In…

Clinical Research in the COVID Era: Learning Lessons, Saving Lives

Doug Peddicord, ACRO’s Executive Director, introduces the series and sheds light on the importance of CROs and technology companies in spearheading clinical innovation through COVID-19 and beyond.

COVID, the role of digital, and the future of clinical research: A conversation with Alistair Macdonald – Part 1

In August 2020, Syneos Health CEO and ACRO Board Chair Alistair Macdonald reflected on the COVID-19 crisis to date. This conversation has been edited lightly for clarity.